Zenas BioPharma, Inc.

ZBIO

ZBIOZenas BioPharma, Inc. US flag

NASDAQ Global Select

17.40

USD

+0.27

- -

776.79MMarket Cap

Income Statement (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Sales/Revenue/Turnover	- -	50	5	10
+ Sales & Services Revenue	- -	50	5	10
- Cost of Revenue	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -
+ Other Operating Income	- -	-50	-5	-10
- Operating Expenses	75	77	169	221
+ Selling, General & Admin	14	17	30	53
+ Research & Development	62	60	139	168
+ Other Operating Expense	- -	- -	- -	- -
Operating Income (Loss)	-75	-27	-164	-211
- Non-Operating (Income) Loss	44	10	-7	166
+ Interest Expense, Net	- -	- -	-8	-5
+ Interest Expense	- -	- -	- -	7
- Interest Income	- -	- -	8	12
+ Other Non-Op (Income) Loss	44	10	1	171
Pretax Income	-119	-37	-157	-378
- Income Tax Expense (Benefit)	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -
Income (Loss) from Cont Ops	-119	-37	-157	-378
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -
Income (Loss) Incl. MI	-119	-37	-157	-378
- Minority Interest	- -	- -	- -	- -
Net Income, GAAP	-119	-37	-157	-378
- Preferred Dividends	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-119	-37	-157	-378
EBIT	-75	-27	-164	-211
EBITDA	-75	-27	-164	-211
EBITDA Margin (%)	- -	-54.07	-3,275.02	-2,113.29
EBITA	-75	-27	-164	-211
Gross Margin (%)	- -	100	100	100
Operating Margin (%)	- -	-54.29	-3,277.76	-2,113.85
Profit Margin (%)	- -	-74.25	-3,139.76	-3,777.37
Sales per Employee	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -
Basic Weighted Avg Shares	13	17	13	- -
Basic EPS, GAAP	-9.26	-2.13	-11.89	- -
Basic EPS from Cont Ops	-9.26	-2.13	-11.89	- -
Diluted Weighted Avg Shares	13	17	13	- -
Diluted EPS, GAAP	-9.26	-2.13	-11.89	- -
Diluted EPS from Cont Ops	-9.26	-2.13	-11.89	- -

Balance Sheet (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Total Current Assets	68	60	356	351
+ Cash, Cash Equivalents & STI	67	57	351	343
+ Cash & Cash Equivalents	67	57	320	111
+ ST Investments	- -	- -	31	233
+ Accounts & Notes Receiv	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -
+ Other ST Assets	1	3	5	8
+ Misc ST Assets	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -
Total Noncurrent Assets	6	8	14	32
+ Property, Plant & Equip, Net	2	1	1	1
+ Property, Plant & Equip	2	1	1	1
- Accumulated Depreciation	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	17
+ LT Investments	- -	- -	- -	17
+ LT Receivables	- -	- -	- -	- -
+ Other LT Assets	4	7	13	14
+ Total Intangible Assets	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -
+ Misc LT Assets	4	7	13	14
Total Assets	75	68	370	384
+ Payables & Accruals	21	18	48	48
+ Accounts Payable	6	5	17	7
+ Accrued Taxes	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -
+ Other Payables & Accruals	15	12	31	41
+ ST Debt	1	1	1	1
+ ST Borrowings	- -	- -	- -	- -
+ ST Finance Leases	1	1	1	1
+ Other ST Liabilities	4	5	8	13
+ Deferred Revenue	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Misc ST Liabilities	4	5	8	13
Total Current Liabilities	26	23	57	63
+ LT Debt	1	21	- -	- -
+ LT Borrowings	- -	20	- -	- -
+ LT Finance Leases	1	- -	- -	- -
+ Other LT Liabilities	240	250	- -	79
+ Accrued Liabilities	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Misc LT Liabilities	240	250	- -	79
Total Noncurrent Liabilities	241	271	- -	79
Total Liabilities	267	294	58	141
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Share Capital & APIC	1	5	700	1,007
+ Common Stock	- -	- -	- -	- -
+ Additional Paid in Capital	1	5	700	1,007
- Treasury Stock	- -	- -	- -	- -
+ Retained Earnings	-193	-230	-387	-765
+ Other Equity	- -	- -	- -	- -
Equity Before Minority Interest	-192	-226	312	242
+ Minority/Non Controlling Interest	- -	- -	- -	- -
Total Equity	-192	-226	312	242
Total Liabilities & Equity	75	68	370	384
Shares Outstanding	40	40	42	54
Number of Employees	- -	- -	- -	- -
Capital Leases - Total	2	1	1	1
Net Debt	-67	-37	-320	-111
Net Debt to Equity	34.95	16.2	-102.33	-45.69
Tangible Common Equity Ratio	-257.83	-331.07	84.46	63.12
Current Ratio	2.64	2.57	6.21	5.61
Cash Conversion Cycle	- -	- -	- -	- -

Cash Flow Statement (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
+ Net Income	-119	-37	-157	-378
+ Depreciation & Amortization	- -	- -	- -	- -
+ Non-Cash Items	46	15	12	204
+ Stock-Based Compensation	1	3	11	26
+ Deferred Income Taxes	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -
+ Other Non-Cash Adj	45	11	1	178
+ Chg in Non-Cash Work Cap	8	-8	25	1
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	-4	-3	-8	-3
+ Inc (Dec) in Accts Payable	13	-4	34	5
+ Inc (Dec) in Other	-1	-1	-1	-1
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Operating Activities	-66	-31	-120	-172
+ Change in Fixed & Intang	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -
+ Acq of Fixed & Intang	-2	- -	- -	-35
+ Acq of Fixed Prod Assets	- -	- -	- -	- -
+ Acq of Intangible Assets	-2	- -	- -	-35
+ Cash (Repurchase) of Equity	- -	- -	241	149
+ Increase in Capital Stock	- -	- -	241	149
+ Decrease in Capital Stock	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	-30	-217
+ Dec in LT Investment	- -	- -	6	201
+ Inc in LT Investment	- -	- -	-36	-418
+ Net Cash From Acq & Div	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Investing Activities	-2	- -	-31	-252
+ Dividends Paid	- -	- -	- -	- -
+ Net Cash From Debt	- -	20	- -	- -
+ Cash From Debt	- -	20	- -	- -
+ Repayments of Debt	- -	- -	- -	- -
+ Other Financing Activities	59	- -	172	67
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Financing Activities	59	20	413	215
Effect of Foreign Exchange Rates	- -	- -	- -	- -
Net Changes in Cash	-8	-10	263	-209
EBITDA	-75	-27	-164	-211
EBITDA Margin (%)	- -	-54.07	-3,275.02	-2,113.29
Free Cash Flow	-68	-31	-120	-207
Net Cash Paid for Acquisitions	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-11	-120	-172
Free Cash Flow per Basic Share	-5.27	-1.75	-9.08	- -
Price/Free Cash Flow	- -	- -	-0.9	- -
Cash Flow to Net Income	0.55	0.82	0.76	0.46
Capital Expenditures	-2	- -	- -	-35